FDA panel says it supports MS drug Tysabri's return to U.S. market

WASHINGTON (AP) - A U.S. Food and Drug Administration panel said Wednesday the agency should allow the multiple-sclerosis drug Tysabri back on the market. The drug's manufacturers, Biogen Idec Inc. and Elan Corp....More